Latest Anti-diabetic drug Stories
BERKELEY, Calif., Nov. 2, 2010 /PRNewswire/ -- What started a year ago as a creative way to encourage people with diabetes to stay active has grown into a global campaign to raise awareness about the benefits of moderate exercise for people with diabetes and help fund two vital diabetes charities.
Crowdsourcing, the act of contracting out problems to large groups rather than tapping individual experts, has solved puzzles in fields such as marketing, engineering and computer software.
RIDGEFIELD, Conn., Sept.
BRIDGEWATER, N.J., Sept. 21 /PRNewswire/ -- Actor Paul Sorvino, living with type 2 diabetes, and his daughter, Academy-award winning actress Mira Sorvino, have teamed up with sanofi-aventis U.S.
A pilot study suggests the diabetes medication pioglitazone is generally well tolerated and may warrant further study as a treatment for patients with Alzheimer's disease.
CLEVELAND, July 29 /PRNewswire/ -- With diabetes affecting the lives of hundreds of thousands of people throughout Ohio and Pennsylvania, Giant EagleÂ®, Inc.
PITTSBURGH, July 29 /PRNewswire/ -- With diabetes affecting the lives of hundreds of thousands of people throughout Pennsylvania and Ohio, Giant EagleÂ®, Inc.
Federal health authorities are prohibiting new patients from enrolling in a safety study for GlaxoSmithKlineâ€™s controversial diabetes pill Avandia, a week after an expert panel ruled that the drug increases heart risks.
The U.S. Food and Drug Administration's (FDA) Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee has completed their evaluation of the scientific research available on the safety of rosiglitazone.
A panel of US Food and Drug Administration advisers voted Wednesday to allow GlaxoSmithKline's diabetes drug Avandia to remain on the market, but with new restrictions due to the risky cardiovascular side effects of the controversial pill.
- A trick or prank.